Table 1.
Comparative table on infectious disease governance between MERS and COVID-19.
| MERS | COVID-19 | |
|---|---|---|
| Status of KCDC | Limited authority | Expanded authority and responsibility |
| Emergency approval | Not available | Available |
| Private sector testing | No fast-track approval system for commercial diagnostic kits | Active |
| Department in charge of testing | No specific division in charge | Division of Laboratory Diagnosis Management, Center for Disease Control and Prevention |